Evid Based Nurs doi:10.1136/eb-2013-101422
  • Child health
  • Cohort study

Prenatal exposure to sodium valproate is associated with increased risk of childhood autism and autistic spectrum disorder

  1. Amanda Wood
  1. Department of Psychology, University of Birmingham, Birmingham, UK
  1. Correspondence to: Dr Amanda Wood, Department of Psychology, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK;

Commentary on:

Implications for practice and research

  • Anticonvulsant drugs increase the risk of poor neurodevelopmental outcome.

  • Women taking sodium valproate should be counselled about potential risks well in advance of pregnancy.

  • Further research is required to understand whether lower doses reduce the risk of autism to population levels.

  • Prospective longitudinal studies assessing all children are necessary to clarify the full extent of risk associated with prenatal medication exposures.


The clinical management of women with epilepsy during pregnancy is complicated by the potential teratogenicity of medications needed to control seizures. Past research about the relationship between prenatal exposure to antiepileptic drugs and major congenital malformations has improved understanding of the immediate effects for the child, with recent studies highlighting the long-term impact on cognitive development.1 ,2 …

No Related Web Pages

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article